✦ LIBER ✦

Donor Lymphocyte Infusion: The Use of Alloreactive and Tumor-Reactive Lymphocytes for Immunotherapy of Malignant and Nonmalignant Diseases in Conjunction with Allogeneic Stem Cell Transplantation

✍ Scribed by Slavin, Shimon; Morecki, Shoshana; Weiss, Lola; Or, Reuven

Book ID: 119959179
Publisher: Mary Ann Liebert
Year: 2002
Tongue: English
Weight: 226 KB
Volume: 11
Category: Article
ISSN: 1061-6128
DOI: 10.1089/152581602753658457

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful second allogeneic peripheral

Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation

✍ Ishikawa, J; Maeda, T; Kashiwagi, H; Yoshida, H; Takahashi, I; Kawamoto, S-I; Ya 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB

Minimal GVHD following in-vitro Tcell–de

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors

✍ Renée M.Y Barge; Susanne Osanto; W.A.F.Erik Marijt; C.W.J.Ingrid Starrenburg; Wi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Prophylactic growth factor-primed donor

Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies

✍ Sang-Kyun Sohn; Jin-Tae Jung; Dong-Hwan Kim; Nan-Young Lee; Kwang-Woon Seo; Yee- 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Brentuximab Vedotin Combined With Donor

Brentuximab Vedotin Combined With Donor Lymphocyte Infusions for Early Relapse of Hodgkin Lymphoma After Allogeneic Stem-Cell Transplantation Induces Tumor-Specific Immunity and Sustained Clinical Remission

✍ Theurich, S.; Malcher, J.; Wennhold, K.; Shimabukuro-Vornhagen, A.; Chemnitz, J. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 981 KB

Efficacy and Safety of Immunomodulation

Efficacy and Safety of Immunomodulation with Fast Withdrawal of Immunosuppression (FWI) and Donor Lymphocyte Infusions (DLI) for Prevention of Relapse in Children Receiving Allogeneic Hematopoietic Stem Cell Transplant (HCT) for Hematologic Malignancies

✍ Horn, Biljana; Petrovic, Aleksandra; Dvorak, Christopher C.; Cowan, Morton J.; W 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Prophylactic donor lymphocyte infusions

Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease

✍ de Lima, M; Bonamino, M; Vasconcelos, Z; Colares, M; Diamond, H; Zalcberg, I; Ta 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 74 KB